If Good Manufacturing Practice (GMP) guidelines feel more like a maze of regulations than a roadmap to action, you’re not alone. Many professionals struggle to translate GMP requirements into clear, ...
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing innovative botanical drugs for the treatment of addictions, announces today the successful ...
The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning letter for a several good manufacturing practice (GMP) violations, including poor aseptic ...
CNBC-TV18 had first reported the US FDA's surprise visit on June 3. The regulator has now issued a Form 483 with eight ...
Glenmark Pharmaceuticals has received a Form 483 with six observations following a US FDA GMP inspection of its Goa ...
Industry calls for greater regulatory handholding for pharma MSMEs to implement Schedule M compliance: Shardul Nautiyal, Mumbai Monday, June 15, 2026, 08:00 Hrs [IST] As India's p ...
This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505(b)(2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...
The partnership represents a significant milestone for ADCAN Pharma as it expands its role as a regional pharmaceutical ...
3don MSNOpinion
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME Day
Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations.
Husband-wife duo Abhinav Garg and Mehak Aggarwal’s book gives an insider’s view of India’s high-stakes pharma manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results